DMGH telemedicine venture with Oxford Instruments Medical enables ambulatory neurological monitoring

New York 02 February 2001Diagnostic Management Group Holdings Inc. (DMGH), a wholly owned subsidiary of Comprehensive Medical Diagnostics Group Inc. (CMDI), a provider of mobile diagnostic services, has signed a contract with Oxford Instruments Medical Inc. to jointly offer ambulatory neurological monitoring in the comfort of a patient's home. Oxford Instruments Medical, a United Kingdom-based company, is a manufacturer of advanced instrumentation to customers in health care, scientific research, and other industries.


Mark Gray, Vice President of DMGH, commented: "This is another step forward in our programme to capture a key segment of the growing telemedicine industry. We are now positioned to be on the cutting edge of ambulatory neurological services." Few companies provide services in this sector of health care. The technical staff employed by CMDI and its subsidiaries, are nationally recognised in the United States for their expertise in neurological monitoring.

The emphasis for the combined array of CMDI companies is to cross market existing services which include Web-based transtelephonic event monitoring, pacemaker checking, 12 lead EKG, halter monitoring, echocardiography, EEG, and bone density testing of semi and ambulatory patients by way of mobile diagnostic services. In addition, the company provides higher end vascular and cardio services, offered through the Cardio Labs unit located at community based hospitals. After completion of the phase one roll-up, the combined companies will service more than 400 long-term care facilities and institutions; hundreds of medical offices; and more than a dozen in-hospital laboratories.

Commonly known as an EEG, this diagnostic test is used to study the brain wave activity, and can confirm clinical suspicion of epilepsy, document seizures of which the patient is unaware, evaluate therapy response, nocturnal or sleep-related events, suspected pseudo-seizures, and syncope. Ambulatory monitoring is especially useful in diagnosing epileptic seizures.

The diagnosis of epilepsy is made from an account of the seizures given to the doctor by the patient and by someone who has actually seen a seizure. Sometimes, there is doubt about the nature of the seizure, in which case it is possible to record the EEG over a period of one or more days, using a small portable EEG recorder which the patient wears on a belt. Recording can thereby be made while the patient carries on normal daytime activities, and during sleep.

Ambulatory EEG monitoring is equally noteworthy in its use in monitoring neurological disorders in children. By making this method available in a comfortable home setting, the child is less intimidated and more likely to co-operate in the monitoring process. The economics are also favourable due to the avoidance of costly hospital stays for patients who do not need hospital care.

DMGH, formerly CAT ECG, has been successful in home patient monitoring since 1969. Its relationships with physicians and hospitals nationwide provides a large base from which to further promote the use of ambulatory EEG in home monitoring. With its long well-established reputation amongst neurologists and associated hospital-based neurology departments, the company is well-positioned to cross market this service amongst its large group of clinical clients.

Leslie Versweyveld

[Medical IT News][Calendar][Virtual Medical Worlds Community][News on Advanced IT]